ce - 医索

找到约 2062 条结果

NCIETCTN 10476 A Randomized, Phase 2 Study ofcombination Atezolizumab and Varlilumab(CDX-1127) withor without addition of Cobimetinib in Previously TreatedUnresectable Biliary Tract Cancer

医客学院 - 会议报告集

Is Timing Everything inGastroesophageal cancers

医客学院 - 会议报告集

International, open-label phase 2 study of regorafenibplus pembrolizumab in patients with advancedhepatocellular carcinoma previously treated withimmune checkpoint inhibitors

医客学院 - 会议报告集

Efficacy and Safety of Cadonilimab in Combination withPulocimab and Paclitaxel as Second-ine Therapy in Patientswith Advanced Gastric or Gastroesophageal Junction (GGEJ)Adenocarcinoma who Fail

医客学院 - 会议报告集

Addition of stereotactic body radiotherapyto systemic chemotherapy in locallyadvanced cholangiocarcinoma(ABC-07)

医客学院 - 会议报告集

A randomized phase ll study of gemcitapine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, andiposomal irinotecan in older patients with treatment-naivemetastatic pancreatic cance

医客学院 - 会议报告集

Trastuzumab and pertuzumab in combination witheribulin mesylate or a taxane as first-linechemotherapeutic treatment for HER2-positive, locallyadvanced or metastatic breast cancer results of amulti

医客学院 - 会议报告集

The ongoing Antibody-Drug conjugatesRevolution in Breast Cancer

医客学院 - 会议报告集

TBCRC 048(0laparib Expanded) Expansion cohortsPhase ll study of olaparib monotherapy in metastatic breast cancer(MBC) patients with germline(g) mutations in PALB2 orsomatic(s) mutations in BRCA1 O

医客学院 - 会议报告集

SACI-0 HR A randomized phase ll trial ofsacituzumab govitecan with or without pembrolizumabin patients with metastatic hormone receptor-positive!HER2-negative breast cancer

医客学院 - 会议报告集

今日实时热搜